Literature DB >> 15089079

Parathyroid hormone.

Gigi R Madore1, Pamela J Sherman, Joseph M Lane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15089079     DOI: 10.5435/00124635-200403000-00001

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


× No keyword cloud information.
  6 in total

1.  Atrophic femoral nonunion successfully treated with teriparatide.

Authors:  S Giannotti; V Bottai; G Dell'Osso; G de Paola; E Pini; G Guido
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-12-09

2.  Recent advances toward the clinical application of PTH (1-34) in fracture healing.

Authors:  Cara A Cipriano; Paul S Issack; Lisa Shindle; Clément M L Werner; David L Helfet; Joseph M Lane
Journal:  HSS J       Date:  2009-03-17

3.  Alendronate inhibits PTH (1-34)-induced bone morphogenetic protein expression in MC3T3-E1 preosteoblastic cells.

Authors:  Paul S Issack; Margaret H Lauerman; David L Helfet; Stephen B Doty; Joseph M Lane
Journal:  HSS J       Date:  2007-03-31

4.  Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.

Authors:  Yuxu Feng; Min Zhou; Qunhu Zhang; Huan Liu; Yong Xu; Lei Shu; Jue Zhang; Dengshun Miao; Yongxin Ren
Journal:  Br J Nutr       Date:  2015-03-06       Impact factor: 3.718

Review 5.  Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials.

Authors:  Ya-Kang Wang; Yu-Min Zhang; Si-Qing Qin; Xu Wang; Tao Ma; Jian-Bin Guo; Chao Zhu; Zhuo-Jing Luo
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

6.  The Efficacy and Safety of Chinese Herbal Medicine Xianling Gubao Capsule Combined With Alendronate in the Treatment of Primary Osteoporosis: A Systematic Review and Meta-Analysis of 20 Randomized Controlled Trials.

Authors:  Jiaru Chen; Junju Zheng; Mangmang Chen; Shenglei Lin; Zhou Lin
Journal:  Front Pharmacol       Date:  2021-07-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.